Immunological aspects of congenital disorders of glycosylation (CDG): a review

Journal of Inherited Metabolic Disease

Volumn 39, Issue 6, 2016, Pages 765-780

  Monticelli, Maria ^a,b   Ferro, Tiago ^a,c   Jaeken, Jaak ^e,f   dos Reis Ferreira, Vanessa ^d,e   Videira, Paula A ^a,c,e  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d Portuguese Association for Congenital Disorders of Glycosylation (CDG)   (Portugal)

^e CDG Allies Professionals and Patient Associations International Network (CDG Allies PPAIN)   (Portugal)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MANNOSIDASE; CARRIER PROTEINS AND BINDING PROTEINS; DOLICHOL KINASE; ISOMERASE; MAGNESIUM TRANSPORTER 1; MANNOSE OLIGOSACCHARIDE 1,2 ALPHA MANNOSIDASE; MANNOSYLOLIGOSACCHARIDE GLYCOSIDASE; PHOSPHOGLUCOMUTASE 3; PHOSPHOMANNOMUTASE 2; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

CONGENITAL DISORDER OF GLYCOSYLATION; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; GALACTOSEMIA; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MAGNESIUM TRANSPORTER 1 DEFICIENCY; PHENOTYPE; PHOSPHOGLUCOMUTASE 3 DEFICIENCY; REVIEW; GENETICS; IMMUNOLOGY; INFLAMMATION;

CONGENITAL DISORDERS OF GLYCOSYLATION; HUMANS; INFLAMMATION; PHENOTYPE;

EID: 84978113399     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-016-9954-9     Document Type: Review

References (123)

1. Al-Essa M, Dhaunsi GS, Al-Qabandi W, Khan I (2013) Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients. Exp Biol Med 238:779–786
2. Anthony RM, Ravetch JV (2010) A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol 30(Suppl 1):S9–14
3. Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473:4–8
4. Arnoux JB, Boddaert N, Valayannopoulos V et al (2008) Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol Genet Metab 93:444–449
5. Barral DC, Brenner MB (2007) CD1 antigen presentation: how it works. Nat Rev Immunol 7:929–941
6. Baum LG, Crocker PR (2009) Glycoimmunology: ignore at your peril! Immunol Rev 230:5–8
7. Bergmann M, Gross HJ, Abdelatty F, Möller P, Jaeken J, Schwartz-Albiez R (1998) Abnormal surface expression of sialoglycans on B lymphocyte cell lines from patients with carbohydrate deficient glycoprotein syndrome I A (CDGS I A). Glycobiology 8:963–972
8. Berry GT (1993) Classic galactosemia and clinical variant galactosemia. In Pagon RA, Adam MP, Ardinger HH et al (Eds.) GeneReviews, Seattle
9. Berry G (2000) Classic galactosemia and clinical variant galactosemia. GeneReviews, Seattle
10. Björklund JE, Stibler H, Kristiansson B, Johansson SG, Magnusson CG (1997) Immunoglobulin levels in patients with carbohydrate-deficient glycoprotein syndrome type I. Int Arch Allergy Immunol 114:116–119
11. Blank C, Smith LA, Hammer DA (2006) Recurrent infections and immunological dysfunction in congenital disorder of glycosylation Ia (CDG Ia). J Inherit Metab Dis 29:592
12. Bosch AM (2006) Classical galactosaemia revisited. J Inherit Metab Dis 29:516–525
13. Buerki SE, Grandgirard D, Datta AN et al (2016) Inflammatory markers in pediatric stroke: an attempt to better understanding the pathophysiology. Eur J Paediatr Neurol 20:252–60
14. Butler M, Quelhas D, Critchley AJ et al (2003) Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology 13:601–622
15. Carlow DA, Gossens K, Naus S, Veerman KM, Seo W, Ziltener HJ (2009) PSGL-1 function in immunity and steady state homeostasis. Immunol Rev 230:75–96
16. Chang J, Block TM, Guo JT (2015) Viral resistance of MOGS-CDG patients implies a broad-spectrum strategy against acute virus infections. Antivir Ther 20:257–259
17. Chantret I, Dupré T, Delenda C et al (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem 277:25815–25822
18. Coman D, Irving M, Kannu P, Jaeken J, Savarirayan R (2008) The skeletal manifestations of the congenital disorders of glycosylation. Clin Genet 73:507–515
19. Coss KP, Hawkes CP, Adamczyk B et al (2014) N-glycan abnormalities in children with galactosemia. J Proteome Res 13:385–94
20. Crespo HJ, Lau JT, Videira PA (2013) Dendritic cells: a spot on sialic acid. Front Immunol 4:491
21. Dauber A, Ercan A, Lee J et al (2014) Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Hum Mol Genet 23:2880–2887
22. de Cock P, Jaeken J (2009) MGAT2 deficiency (CDG-IIa): the life of J. Biochim Biophys Acta 1792:844–846
23. De Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W (1993) Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177:657–666
24. de la Morena-Barrio ME, Hernández-Caselles T, Corral J et al (2013) GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients. Orphanet J Rare Dis 8:170
25. de Lonlay P, Seta N, Barrot S et al (2001) A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 38:14–19
26. De Praeter CM, Gerwig GJ, Bause E et al (2000) A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 66:1744–1756
27. Demellawy DE, Chang N, de Nanassy J, Nasr A (2015) GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis. Scand J Rheumatol 44:170–172
28. Dhalla F, Murray S, Sadler R et al (2015) Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J Clin Immunol 35:112–118
29. Di Rocco M, Hennet T, Grubenmann CE et al (2005) Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature. J Inherit Metab Dis 28:1162–1164
30. Dupré T, Barnier A, de Lonlay P et al (2000) Defect in N-glycosylation of proteins is tissue-dependent in congenital disorders of glycosylation Ia. Glycobiology 10:1277–1281
31. Eklund EA, Newell JW, Sun L et al (2005) Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. Mol Genet Metab 84:25–31
32. Etzioni A, Tonetti M (2000) Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95:3641–3643
33. Etzioni A, Frydman M, Pollack S et al (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327:1789–1792
34. Freeze H, Schachter H et al (2009) Genetic disorders of glycosylation. In: Varki A, Cummings R, Esko J (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, New York
35. Frydman M, Etzioni A, Eidlitz-Markus T et al (1992) Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet 44:297–302
36. Goreta SS, Dabelic S, Dumic J (2012) Insights into complexity of congenital disorders of glycosylation. Biochem Med 22:156–170
37. Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T (2002) ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. Hum Mol Genet 11:2331–2339
38. Grubenmann CE, Frank CG, Hülsmeier AJ et al (2004) Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Hum Mol Genet 13:535–542
39. Grunewald S (2009) The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 1792:827–834
40. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R (2009) Severe sepsis in cirrhosis. Hepatology 50:2022–33
41. Hayes JM, Cosgrave EF, Struwe WB et al (2014) Glycosylation and Fc receptors. Curr Top Microbiol Immunol 382:165–99
42. He P, Srikrishna G, Freeze HH (2014) N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory response. Glycobiology 24:392–398
43. Helmus Y, Denecke J, Yakubenia S et al (2006) Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood 107:3959–3966
44. Heyne K, Mayatepek E, Walther F, Weidinger S, Pahl HL (1998) Pericardial effusion in glycanosis CDG type I (MIM 212 065): an inflammatory endoplasmic reticulum overload response? Eur J Pediatr 157:168–169
45. Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS (2003) Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood 101:1705–1712
46. Huybrechts S, De Laet C, Bontems P et al (2012) Deficiency of subunit 6 of the conserved oligomeric golgi complex (COG6-CDG): second patient, different phenotype. JIMD Rep 4:103–108
47. Ilkovski B, Pagnamenta AT, O’Grady GL et al (2015) Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies. Hum Mol Genet 24:6146–6159
48. Imtiaz F, Worthington V, Champion M et al (2000) Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type I. J Inherit Metab Dis 23:162–174
49. Jaeken J (2012) MGAT2-CDG (CDG-IIa) and dysmorphism. Am J Med Genet 158A:2974–2975
50. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, Eeckels R (1980) Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr Res 14:179
51. Jaeken J, De Cock P, Stibler H et al (1993) Carbohydrate-deficient glycoprotein syndrome type II. J Inherit Metab Dis 16:1041
52. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G (1994) Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 71:123–127
53. Jaeken J, Matthijs G, Barone R, Carchon H (1997) Carbohydrate deficient glycoprotein (CDG) syndrome type I. J Med Genet 34:73–76
54. Jaeken J, Hennet T, Matthijs G, Freeze HH (2009) CDG nomenclature: time for a change! Biochim Biophys Acta 1792:825–826
55. Jamieson JC, McCaffrey G, Harder PG (1993) Sialyltransferase: a novel acute-phase reactant. Comp Biochem Physiol B 105:29–33
56. Jensen T, Galli-Stampino L, Mouritsen S et al (1996) T cell recognition of Tn-glycosylated peptide antigens. Eur J Immunol 26:1342–9
57. Kapusta L, Zucker N, Frenckel G et al (2013) From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG). Heart Fail Rev 18:187–196
58. Kjaergaard S, Schwartz M, Skovby F (2001) Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child 85:236–239
59. Kobayashi RH, Kettelhut BV, Kobayashi AL (1983) Galactose inhibition of neonatal neutrophil function. Pediatr Infect Dis 2:442–445
60. Kranz C, Denecke J, Lehle L et al (2004) Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. Am J Hum Genet 74:545–551
61. Kranz C, Basinger AA, Güçsavaş-Calikoğlu M et al (2007a) Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am J Med Genet A 143A:1371–1378
62. Kranz C, Jungeblut C, Denecke J et al (2007b) A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Genet 80:433–440
63. Kundak AA, Zenciroğlu A, Yaralı N et al (2012) An unusual presentation of galactosemia: hemophagocytic lymphohistiocytosis. Turk J Haematol 29:401–404
64. Li FY, Chaigne-Delalande B, Kanellopoulou C et al (2011) Signaling role for Mg(2+) revealed by immunodeficiency due to loss of MagT1. Nature 475:471–476
65. Lieu MT, Ng BG, Rush JS et al (2013) Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation. Mol Genet Metab 110:484–489
66. Litchfield WJ, Wells WW (1978) Effect of galactose on free radical reactions of polymorphonuclear leukocytes. Arch Biochem Biophys 188:26–30
67. Lübbehusen J, Thiel C, Rind N et al (2010) Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. Hum Mol Genet 19:3623–3633
68. Lübke T, Marquardt T, von Figura K, Körner C (1999) A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J Biol Chem 274:25986–25989
69. Lühn K, Marquardt T, Harms E, Vestweber D (2001) Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts. Blood 97:330–332
70. Lundin KE, Hamasy A, Backe PH et al (2015) Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene. Clin Immunol 161:366–372
71. Lyons JJ, Milner JD, Rosenzweig SD (2015) Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology. Front Pediatr 3:54
72. Maratha A, Stockmann H, Coss KP et al (2016) Classical galactosemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis. Eur J Hum Genet doi: 10.1038/ejhg.2015.254
73. Marquardt T, Brune T, Lühn K et al (1999a) Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr 134:681–688
74. Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D (1999b) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94:3976–3985
75. Matthijs G, Schollen E, Pardon E et al (1997) Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 16:88–92
76. Metzker A, Eisenstein B, Oren J, Samuel R (1988) Tumoral calcinosis revisited—common and uncommon features. Report of ten cases and review. Eur J Pediatr 147:128–132
77. Molinari F, Foulquier F, Tarpey PS et al (2008) Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet 82:1150–1157
78. Monin ML, Mignot C, De Lonlay P et al (2014) 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis 9:207
79. Morava E, Vodopiutz J, Lefeber DJ et al (2012) Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 130:e1034–1039
80. Moremen KW, Trimble RB, Herscovics A (1994) Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology 4:113–125
81. Murali C, Lu JT, Jain M et al (2014) Diagnosis of ALG12-CDG by exome sequencing in a case of severe skeletal dysplasia. Mol Genet Metab Rep 1:213–219
82. Nasirikenari M, Segal BH, Ostberg JR, Urbasic A, Lau JT (2006) Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood 108:3397–3405
83. Noelle V, Knuepfer M, Pulzer F et al (2005) Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema. Eur J Pediatr 164:223–226
84. Ong BB, Gole GA, Robertson T, McGill J, de Lore D, Crawford M (2009) Retinal hemorrhages associated with meningitis in a child with a congenital disorder of glycosylation. Forensic Sci Med Pathol 5:307–312
85. Pérez-Dueñas B, García-Cazorla A, Pineda M et al (2009) Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Eur J Paediatr Neurol 13:444–451
86. Piton A, Redin C, Mandel JL (2013) XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet 93:368–383
87. Pokrovskaya ID, Willett R, Smith RD, Morelle W, Kudlyk T, Lupashin VV (2011) Conserved oligomeric Golgi complex specifically regulates the maintenance of Golgi glycosylation machinery. Glycobiology 21:1554–1569
88. Priatel JJ, Chui D, Hiraoka N et al (2000) The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12:273–283
89. Ramaekers VT, Stibler H, Kint J, Jaeken J (1991) A new variant of the carbohydrate deficient glycoproteins syndrome. J Inherit Metab Dis 14:385–388
90. Richard E, Vega AI, Pérez B et al (2009) Congenital disorder of glycosylation Ia: new differentially expressed proteins identified by 2-DE. Biochem Biophys Res Commun 379:267–271
91. Rohlfing AK, Rust S, Reunert J et al (2014) ALG1-CDG: a new case with early fatal outcome. Gene 534:345–351
92. Rymen D, Jaeken J (2014) Skin manifestations in CDG. J Inherit Metab Dis 37:699–708
93. Rymen D, Peanne R, Millón MB et al (2013) MAN1B1 deficiency: an unexpected CDG-II. PLoS Genet 9:e1003989
94. Rymen D, Winter J, Van Hasselt PM et al (2015) Key features and clinical variability of COG6-CDG. Mol Genet Metab 116:163–170
95. Sadat MA, Moir S, Chun TW et al (2014) Glycosylation, hypogammaglobulinemia, and resistance to viral infections. N Engl J Med 370:1615–1625
96. Saldova R, Stöckmann H, O’Flaherty R, Lefeber DJ, Jaeken J, Rudd PM (2015) N-glycosylation of serum IgG and total glycoproteins in MAN1B1 deficiency. J Proteome Res 14:4402–4412
97. Sassi A, Lazaroski S, Wu G et al (2014) Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol 133:1410–1419
98. Scott K, Gadomski T, Kozicz T, Morava E (2014) Congenital disorders of glycosylation: new defects and still counting. J Inherit Metab Dis 37:609–617
99. Serrano M, de Diego V, Muchart J et al (2015) Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment. Orphanet J Rare Dis 10:138
100. Shaheen R, Ansari S, Alshammari MJ et al (2013) A novel syndrome of hypohidrosis and intellectual disability is linked to COG6 deficiency. J Med Genet 50:431–436
101. Silva Z, Konstantopoulos K, Videira PA (2012) The role of sugars in dendritic cell trafficking. Ann Biomed Eng 40:777–789
102. Sparks SE, Krasnewich DM (2005) Congenital disorders of n-linked glycosylation pathway overview. In: Pagon RA, Adam MP, Ardinger HH et al (Eds.) GeneReviews. Seattle (WA): University of Washington, Seattle. Available from http://www.ncbi.nlm.nih.gov/books/NBK1332/
103. Sperandio M, Gleissner CA, Ley K (2009) Glycosylation in immune cell trafficking. Immunol Rev 230:97–113
104. \Stanley P, Guidos CJ (2009) Regulation of Notch signaling during T- and B-cell development by O-fucose glycans. Immunol Rev 230:201–15
105. Stanley P, Schachter H, Taniguchi N et al (2009) N-Glycans. In: Varki A, Cummings R, Esko J (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, New York
106. Stibler H, Blennow G, Kristiansson B, Lindehammer H, Hagberg B (1994) Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatry 57:552–556
107. Stray-Pedersen A, Backe PH, Sorte HS et al (2014) PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet 95:96–107
108. Strømme P, Maehlen J, Strøm EH, Torvik A (1991) Postmortem findings in two patients with the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand Suppl 375:55–62
109. Thiel C, Schwarz M, Hasilik M et al (2002) Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. Biochem J 367(Pt 1):195–201
110. Truin G, Guillard M, Lefeber DJ et al (2008) Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia. Mol Genet Metab 94:481–484
111. van de Kamp JM, Lefeber DJ, Ruijter GJ et al (2007) Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J Med Genet 44:277–280
112. Van Dijk W, Brinkman-Van der Linden ECM, Havenaar EC (1998) Glycosylation of alpha1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications. Trens Glycosci Glycotechnol 10:235–245
113. Van Dijk W, Koeleman C, Van het Hof B, Poland D, Jakobs C, Jaeken J (2001) Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). FEBS Lett 494:232–235
114. Van Schaftingen E, Jaeken J (1995) Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 377:318–320
115. Van Scherpenzeel M, Timal S, Rymen D et al (2014) Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain 137:1030–1038
116. Varki A, Gagneux P (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253:16–36
117. Verma S, Bharti B, Inusha P (2010) Association of fungal sepsis and galactosemia. Indian J Pediatr 77:695–696
118. Verstegen RH, Theodore M, van de Klerk H, Morava E (2012) Lymphatic edema in congenital disorders of glycosylation. JIMD Rep 4:113–116
119. Videira PA, Amado IF, Crespo HJ et al (2008) Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J 25:259–68
120. Vogt G, Chapgier A, Yang K et al (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 37:692–700
121. Waggoner DD, Buist NR, Donnell GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 13:802–818
122. Wu G, Hitchen PG, Panico M et al (2015) Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation. Glycoconj J doi: 10.1007/s10719-015-9638-y
123. Zhang Y, Yu X, Ichikawa M et al (2014) Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 133:1400–1409